These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19957105)

  • 1. Feasibility and usefulness of training assertive community treatment team in cognitive behavioral therapy.
    Pinninti NR; Fisher J; Thompson K; Steer R
    Community Ment Health J; 2010 Aug; 46(4):337-41. PubMed ID: 19957105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do community mental health teams caring for severely mentally ill patients adjust treatments and services based on patients' antisocial or criminal behaviours?
    Hodgins S; Cree A; Khalid F; Patel K; Sainz-Fuertes R; Shortt M; Mak T; Riaz M
    Eur Psychiatry; 2009 Sep; 24(6):373-9. PubMed ID: 19726165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assertive community treatment for the seriously mentally ill in suburban Sydney: a programme description and evaluation.
    Hambridge JA; Rosen A
    Aust N Z J Psychiatry; 1994 Sep; 28(3):438-45. PubMed ID: 7893238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assertive community treatment in the Netherlands: a randomized controlled trial.
    Sytema S; Wunderink L; Bloemers W; Roorda L; Wiersma D
    Acta Psychiatr Scand; 2007 Aug; 116(2):105-12. PubMed ID: 17650271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalizability of brief psychiatric rating scale prototypical profiles and their use in evaluating treatment outcomes.
    Burger GK; Yonker RD; Calsyn RJ; Morse GA; Klinkenberg WD
    Int J Methods Psychiatr Res; 2005; 14(1):56-64. PubMed ID: 16097400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating treatment with rehabilitation for persons with major mental illnesses.
    Kopelowicz A; Liberman RP
    Psychiatr Serv; 2003 Nov; 54(11):1491-8. PubMed ID: 14600308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition to low intensity case management in a VA Assertive Community Treatment model program.
    Rosenheck RA; Neale MS; Mohamed S
    Psychiatr Rehabil J; 2010; 33(4):288-96. PubMed ID: 20374987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome in patients receiving assertive community treatment.
    Kortrijk HE; Mulder CL; Roosenschoon BJ; Wiersma D
    Community Ment Health J; 2010 Aug; 46(4):330-6. PubMed ID: 19847646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health service use by children with serious emotional and behavioral disturbance: results from the LAMS study.
    Mendenhall AN; Demeter C; Findling RL; Frazier TW; Fristad MA; Youngstrom EA; Arnold LE; Birmaher B; Gill MK; Axelson D; Kowatch RA; Horwitz SM
    Psychiatr Serv; 2011 Jun; 62(6):650-8. PubMed ID: 21632735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral health interventions being implemented in a VA primary care system.
    Funderburk JS; Sugarman DE; Labbe AK; Rodrigues A; Maisto SA; Nelson B
    J Clin Psychol Med Settings; 2011 Mar; 18(1):22-9. PubMed ID: 21350951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacist interventions on an assertive community treatment team.
    Gable KN; Stunson MJ
    Community Ment Health J; 2010 Aug; 46(4):351-5. PubMed ID: 19809876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief integrated outpatient dual-diagnosis treatment reduces psychiatric hospitalizations.
    Granholm E; Anthenelli R; Monteiro R; Sevcik J; Stoler M
    Am J Addict; 2003; 12(4):306-13. PubMed ID: 14504023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving implementation of evidence based practice for people with psychosis through training the wider workforce: Results of the GOALS feasibility randomised controlled trial.
    Waller H; Landau S; Fornells-Ambrojo M; Jolley S; McCrone P; Halkoree R; Basit N; Iredale C; Tunnard C; Zala D; Craig TJK; Garety P
    J Behav Ther Exp Psychiatry; 2018 Jun; 59():121-128. PubMed ID: 29351861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Ostacher MJ; Perlis RH; Nierenberg AA; Calabrese J; Stange JP; Salloum I; Weiss RD; Sachs GS;
    Am J Psychiatry; 2010 Mar; 167(3):289-97. PubMed ID: 20008948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.
    Dixon LB; Dickerson F; Bellack AS; Bennett M; Dickinson D; Goldberg RW; Lehman A; Tenhula WN; Calmes C; Pasillas RM; Peer J; Kreyenbuhl J;
    Schizophr Bull; 2010 Jan; 36(1):48-70. PubMed ID: 19955389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing Illness Management and Recovery Within Assertive Community Treatment: A Pilot Trial of Feasibility and Effectiveness.
    Monroe-DeVita M; Morse G; Mueser KT; McHugo GJ; Xie H; Hallgren KA; Peterson R; Miller J; Akiba C; York M; Gingerich S; Stiles B
    Psychiatr Serv; 2018 May; 69(5):562-571. PubMed ID: 29446335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.